Fidelion Diagnostics Pte. Ltd.
CIK: 0002104953
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BGLC
BioNexus Gene Lab Corp
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About FIDELION DIAGNOSTICS PTE. LTD.
FIDELION DIAGNOSTICS PTE. LTD. (SEC CIK 0002104953) files insider reports with the SEC as BioNexus Gene Lab Corp (BGLC).
Signal8 holds 1 ownership filing by FIDELION DIAGNOSTICS PTE. LTD., a Form 3, filed on Aug 7, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on FIDELION DIAGNOSTICS PTE. LTD.'s filings is in SINGAPORE.
Other insiders filing for BioNexus Gene Lab Corp (BGLC)
- Tan Lee Su-Leng, Chief Executive Officer
- Yap Chee Keong, Director
- Bin Abdul Hamid Muhammad Azrul, Director
- Chong Set Fui, Chief Financial Officer
- Low Jook Yuen, Director